Abstract |
The chemopreventive effects of Ibuprofen on the development and growth of 7,12-dimethylbenz(a)anthracene (DMBA) induced rat mammary tumors were examined. A well known breast cancer chemopreventive retinoid, N-(4-hydroxyphenyl) retinamide (4-HPR) was also included in this study for comparison. At 7 days prior to receiving a single intragastric dose of 15 mg DMBA, rats were fed a control chow diet, as well as diets containing either 1000 mg/kg diet of Ibuprofen or 1.5 mmol/kg diet of 4-HPR. Ibuprofen and 4-HPR markedly increased tumor latency. At 112 days post DMBA intubation, tumor incidence was 86% in control rats as compared to 74% and 62% in rats receiving Ibuprofen, and 4-HPR diets respectively (p < 0.05). Ibuprofen and 4-HPR reduced tumor burden and tumor volume almost to the same extent. The control rats had an average of 2.26 tumors/rat compared to 1.42 and 1.46 tumors/rat in the Ibuprofen or 4-HPR groups respectively (p < 0.05). Similarly, average tumor volume was 3.25 cm3 in the control rats compared to 0.86 cm3 and 0.83 cm3 in rats receiving Ibuprofen and 4-HPR diets respectively (p < 0.05). These results suggest that Ibuprofen may have potential in the chemoprevention and treatment of breast cancer.
|
Authors | G A Alshafie, R E Harris, F M Robertson, M L Parrett, M Ross, H Abou-Issa |
Journal | Anticancer research
(Anticancer Res)
1999 Jul-Aug
Vol. 19
Issue 4B
Pg. 3031-6
ISSN: 0250-7005 [Print] Greece |
PMID | 10652588
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Anticarcinogenic Agents
- Fenretinide
- Ibuprofen
|
Topics |
- Adenocarcinoma
(pathology, prevention & control)
- Animals
- Anticarcinogenic Agents
(pharmacology)
- Female
- Fenretinide
(pharmacology)
- Ibuprofen
(pharmacology)
- Mammary Neoplasms, Experimental
(pathology, prevention & control)
- Rats
- Rats, Sprague-Dawley
|